Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
10.54
-0.32 (-2.95%)
Nov 20, 2024, 4:00 PM EST - Market closed
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $472.08 million as of November 21, 2024. Its market cap has increased by 96.77% in one year.
Market Cap
472.08M
Enterprise Value
405.03M
1-Year Change
96.77%
Ranking
Category
Stock Price
$10.54
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $472.08M, a decrease of -40.75%. That is a compound annual growth rate of -8.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 499.29M |
| GRAIL | 496.96M |
| PureTech Health | 491.58M |
| Arcturus Therapeutics Holdings | 489.20M |
| Theravance Biopharma | 487.81M |
| Treace Medical Concepts | 483.43M |
| Zevra Therapeutics | 478.78M |
| Esperion Therapeutics | 474.85M |